ALB and acute myeloid leukemia: The HCT-CI has been repeatedly adjusted by adding parameters such as age with a cut-off at 40 years (HCT-CI/age), ferritin, albumin, and platelets (augmented HCT-CI) or combinations of augmented HCT-CI, age risk groups, as well as cytogenetic and molecular risk groups (AML composite model, AML-CM) [19,20,21].